Global Oral Live Cholera Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Oral Live Cholera Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines.
Oral Live Cholera Vaccines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oral Live Cholera Vaccines market is projected to reach US$ 143.7 million in 2029, increasing from US$ 85 million in 2022, with the CAGR of 7.0% during the period of 2024 to 2029. Demand from Prevention and Emergency Response are the major drivers for the industry.
Factors such as increasing incidence of cholera outbreaks, rising awareness about the disease and its prevention, and government initiatives to control cholera are driving market growth. Oral live cholera vaccines offer advantages such as ease of administration, cost-effectiveness, and potential for herd immunity. The market is characterized by the presence of both established pharmaceutical companies and emerging players. However, challenges such as vaccine storage and distribution requirements, limited accessibility in resource-constrained regions, and the need for cold chain maintenance may pose obstacles to market expansion.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Live Cholera Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
PaxVax
Sanofi
Valneva
EuBiologics
Shanghai United Cell Biotechnology
Vabiotech
Segment by Type
Euvichol- Plus
DUKORAL
Shanchol
Others
Prevention
Emergency Response
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oral Live Cholera Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Live Cholera Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Live Cholera Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oral Live Cholera Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Live Cholera Vaccines introduction, etc. Oral Live Cholera Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Oral Live Cholera Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Oral Live Cholera Vaccines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oral Live Cholera Vaccines market is projected to reach US$ 143.7 million in 2029, increasing from US$ 85 million in 2022, with the CAGR of 7.0% during the period of 2024 to 2029. Demand from Prevention and Emergency Response are the major drivers for the industry.
Factors such as increasing incidence of cholera outbreaks, rising awareness about the disease and its prevention, and government initiatives to control cholera are driving market growth. Oral live cholera vaccines offer advantages such as ease of administration, cost-effectiveness, and potential for herd immunity. The market is characterized by the presence of both established pharmaceutical companies and emerging players. However, challenges such as vaccine storage and distribution requirements, limited accessibility in resource-constrained regions, and the need for cold chain maintenance may pose obstacles to market expansion.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Live Cholera Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
PaxVax
Sanofi
Valneva
EuBiologics
Shanghai United Cell Biotechnology
Vabiotech
Segment by Type
Euvichol- Plus
DUKORAL
Shanchol
Others
Segment by Application
Prevention
Emergency Response
Segment by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oral Live Cholera Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Live Cholera Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Live Cholera Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oral Live Cholera Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Live Cholera Vaccines introduction, etc. Oral Live Cholera Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Oral Live Cholera Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices